Clonal hematopoiesis variants appear to outnumber tumor mutations in the plasma of most cancer patients, the investigators found in their study.

Microbiology lab and industry stakeholders are increasingly working together to coordinate approaches and generate more clinical utility data for diagnostic testing.

In a notice posted on its website, the Competition and Markets Authority said it is extending its inquiry, with a new deadline of Feb. 5, 2020.

The editors of six major scientific journals criticize a rule proposed by the US Environmental Protection Agency, Science News reports.

The Associated Press gives a rundown of what little is known about He Jiankui and the twin girls since his announcement last year that he had edited their genomes as embryos.

Researchers report on the use of Wolbachia to make mosquitos resistance to dengue fever and other mosquito-borne disease.

In Genome Biology this week: analysis of gut microbiomes from the Hispanic Community Health Study/Study of Latinos, collection of patient-derived tumor cells from gynecological cancers, and more.

The financing will go toward building out its sales teams in the US and Europe in order to market its multiplexed MDx tests for infectious diseases.

A longitudinal household study suggests patients can acquire methicillin-resistant or sensitive Staphylococcus aureus from household members, pets, and surfaces.

Swedish genetic test developer Devyser has launched the HBOC kit for hereditary breast and ovarian cancer testing. The kit is based on Devyser's proprietary next-generation sequencing library prep technology, and provides targeted sequencing of 12 genes in which mutations are associated with an increased risk of developing breast and ovarian cancer. The company said that the workflow takes less than 45 minutes. The HBOC kit is part of Devyser's NGS Oncology suite, complementing the company's BRCA kit that enables simultaneous screening of mutations in the BRCA1 and BRCA2 genes. The new kit is available in the EU and through Devyser distributors in several countries in the Middle East, Southeast Asia, China, South America, and Africa. Customers in countries in which Devyser does not have distributors currently (e.g. the US and Canada) can self-import the assay, a company spokesperson said.

Researchers at the Jackson Laboratory have tested an early version of the GenapSys sequencer and found it to have a very low mismatch error rate.

The method, dubbed GoPhAST-R, was codeveloped by researcher from the Broad Institute and NanoString, which now hopes to work with a partner to commercialize it.

Geisinger researchers will work with collaborators at the nonprofit FH Foundation to develop new methods for the identification and cascade testing of FH.

The partners are developing a new lab that will focus on research into protein biomarkers with medical, agricultural, and environmental applications.

Carnegie Mellon University and Elsevier make a "read-and-publish" deal, Inside Higher Ed reports.

According to the Associated Press, police in Germany are seeking DNA samples from 900 men to tackle a cold case.

Forbes reports on firms using artificial intelligence to diagnose rare genetic diseases.

In PNAS this week: genomic analysis of the venomous Hispaniolan solenodon, Epstein-Barr virus amplification in replication compartments, and more.

A group led by Mount Sinai researchers said this methyltransferase, which is involved in sporulation, could be targeted to fight infections.

The test, which will be developed using the companies' respective technologies, will be marketed by Biolidics following clinical validation.

10x Genomics has launched its Visium Spatial Gene Expression solution. The assay provides researchers the ability to map where gene activity is occurring in a tissue specimen, with whole-transcriptome analysis of up to hundreds of thousands of cells on a tissue section.

Visium builds on earlier products from Spatial Transcriptomics, which 10x acquired in 2018, offering five times more spots within a capture area while reducing the time it takes from three days to one day.

Visium also includes turn-key software and requires access to an optical microscope.

The firm's diagnostics and genomics group saw a 5 percent year-over-year revenue increase in the fourth quarter.

A regional court said certain 10x Genomics' products, including older GEM chips and some Chromium instruments, infringed a "utility model," similar to a patent.

PWNHealth will enable Stratify to offer its Prompt Personal Genetic Score prostate cancer genetic risk test directly to consumers with medical oversight.

A survey by University of Nebraska researchers found that both specialists and primary care healthcare providers largely interpreted genetic testing results correctly.